Search

A study conducted at Yidu Central Hospital Weifang in China has developed a nomogram to predict the recurrence of early-stage glottic cancer (EGC) following transoral laser microsurgery (TLM). The researchers analyzed the clinical and computed tomography (CT) features of 168 patients with EGC, both with and without recurrence. They found that T-stage, depth, and normalized CT values were independent predictors of recurrence. The nomogram, which incorporates these variables, showed good prediction accuracy and may serve as a noninvasive tool for guiding personalized treatment. [Extracted from the article]

The article explores the effects of 3D conformal hypofractionated radiotherapy on early-stage glottic cancer patients, focusing on voice quality and oncological outcomes. Topics discussed include the significant improvement in voice quality post-treatment, the specific regimen of hypofractionated radiotherapy used, and the evaluation of voice handicap index scores before and after treatment.

A study conducted at the University of Miami compared the use of a 445-nm blue laser (BL) and a 532-nm potassium-titanyl-phosphate (KTP) laser for the treatment of early glottic carcinoma. The study found that both lasers were equally safe and effective in removing the carcinoma, with no significant differences in oncologic outcomes. Both laser groups also showed significant improvement in voice outcomes following surgery. Further research is needed to assess long-term outcomes for patients treated with the blue laser. [Extracted from the article]

A recent study conducted by Johns Hopkins University investigated the factors that impact treatment decision-making in early glottic carcinoma (EGC), a type of glottic cancer. The study surveyed laryngologists, head-and-neck surgeons, and radiation oncologists, presenting them with different cases of EGC and asking for their treatment preferences and the factors that influenced their recommendations. The study found that anterior commissure involvement and laterality were the most important tumor factors for treatment recommendations. Additionally, the study revealed that laryngologists were more likely to recommend transoral laser microsurgery (TLMS) for T2 lesions compared to head-and-neck surgeons and radiation oncologists. The study concluded that there is a need for increased understanding of how tumor location and depth impact voice outcomes in order to better inform treatment decisions. [Extracted from the article]

A study conducted by researchers at the University of Toyama in Japan examined the outcomes of accelerated fractionated radiation therapy for N0 glottic carcinoma, a type of cancer affecting the vocal cords. The study included 29 patients who received radiation therapy for their condition. The results showed a 3-year local control rate of 95.6% with no lymph node or distant recurrence. The researchers concluded that accelerated fractionated radiation therapy may be a viable option for the treatment of N0 glottic carcinoma due to its ability to shorten treatment time. [Extracted from the article]

A new study conducted by researchers at Amrita Vishwa Vidyapeetham has found that a hypofractionated radiotherapy schedule of 60Gy in 20 fractions over four weeks offers comparable local disease control with reasonable long-term side effects in T1 glottic cancer. The study included 105 patients with stage I glottic cancer who received this treatment, and the primary objective was to assess locoregional control. The study found that the disease-free survival at five years and ten years were 83% and 69%, and overall survival at five years and ten years were 87% and 80%, respectively. The majority of patients reported grade I skin reactions and tolerated the treatment well, with no observed late adverse events. [Extracted from the article]

A recent study conducted at the Army Hospital Research and Referral compared the short-term phonatory outcomes of laser surgery and radiotherapy in patients with early glottic cancer. The study found that laser surgery had a more favorable immediate effect on voice parameters such as jitter, shimmer, harmonics-to-noise ratio, and fundamental frequency. However, after a 3-month period, both treatment modalities demonstrated similar effects. The researchers concluded that treating physicians should consider various factors such as complications, patient-specific considerations, treatment costs, and duration when making treatment decisions for T1 laryngeal cancer. [Extracted from the article]

A recent study conducted at the University of Health Sciences in Ankara, Turkey, examined the outcomes of hypofractionation treatment for early-stage glottic carcinoma. The study analyzed 33 patients who were treated with intensity-modulated radiotherapy (IMRT) between June 2016 and January 2021. The researchers found that hypofractionation with 2.25 Gy per fraction may be a viable treatment option for early glottic carcinoma, producing similar results to microsurgery and conventional fractionation radiotherapy. The study concluded that further research is needed to validate these findings. [Extracted from the article]

A recent study conducted in India examined the treatment options for early glottic cancer, specifically focusing on transoral laser microsurgery (TLM). The study found that TLM is a safe and effective treatment for early glottic carcinoma, with comparable oncological benefits to open partial laryngectomy (OPL) and radiation therapy (RT). The study also highlighted the importance of considering anterior commissure involvement (ACI) and frozen margin positivity as negative predictive factors. The findings suggest that ACI should be taken into account when staging glottic tumors and that vigilant follow-up is necessary for patients with frozen margin positivity. [Extracted from the article]

A study conducted by Dalhousie University in Halifax, Canada, explored the management of positive resection margins (PMs) following transoral laser microsurgery (TLM) for glottic squamous cell carcinoma (SCC). The study found that re-resection was an appropriate treatment for cases of PMs, based on long-term data collected from 2007 to 2018. Close observation as a management strategy for PMs was discontinued due to a high rate of recurrence. The study concluded that re-resection is an effective treatment option for early-stage glottic SCC. [Extracted from the article]

Keywords: Taipei; Taiwan; Asia; Cancer; Cordectomy; Drugs and Therapies; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Oncology; Radiotherapy; Surgery EN Taipei Taiwan Asia Cancer Cordectomy Drugs and Therapies Glottic Cancer Glottic Carcinoma Health and Medicine Oncology Radiotherapy Surgery 596 596 1 11/06/23 20231110 NES 231110 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on Oncology - Glottic Cancer have been presented. Taipei, Taiwan, Asia, Cancer, Cordectomy, Drugs and Therapies, Glottic Cancer, Health and Medicine, Oncology, Radiotherapy, Surgery, Glottic Carcinoma. [Extracted from the article]

Keywords: Ankara; Turkey; Eurasia; Cancer; Cordectomy; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Microsurgery; Oncology; Operative Surgical Procedures; Surgery EN Ankara Turkey Eurasia Cancer Cordectomy Glottic Cancer Glottic Carcinoma Health and Medicine Microsurgery Oncology Operative Surgical Procedures Surgery 1533 1533 1 10/30/23 20231103 NES 231103 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Data detailed on Oncology - Glottic Cancer have been presented. Ankara, Turkey, Eurasia, Cancer, Cordectomy, Glottic Cancer, Glottic Carcinoma, Health and Medicine, Microsurgery, Oncology, Operative Surgical Procedures, Surgery. [Extracted from the article]

Keywords: Fukuoka; Japan; Asia; Alkylating Agents; Antineoplastics; Cancer; Chlorine Compounds; Cisplatin Therapy; Drugs and Therapies; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Nitrogen Compounds; Oncology; Pharmaceuticals; Platinum Compounds; Radiation Therapy; Squamous Cell Carcinoma EN Fukuoka Japan Asia Alkylating Agents Antineoplastics Cancer Chlorine Compounds Cisplatin Therapy Drugs and Therapies Glottic Cancer Glottic Carcinoma Health and Medicine Nitrogen Compounds Oncology Pharmaceuticals Platinum Compounds Radiation Therapy Squamous Cell Carcinoma 602 602 1 10/24/23 20231024 NES 231024 2023 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Oncology - Squamous Cell Carcinoma. For more information on this research see: Comparative Treatment Outcome In T3n0 Glottic Cancer With and Without Vocal Fold Fixation Receiving Radiation Therapy and Concurrent Low-dose Intra-arterial Cisplatin Infusion. [Extracted from the article]

Keywords for this news article include: Birmingham, Alabama, United States, North and Central America, Cancer, Glottic Cancer, Glottic Carcinoma, Health and Medicine, Oncology, University of Alabama Birmingham. Keywords: Birmingham; State:Alabama; United States; North and Central America; Cancer; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Oncology EN Birmingham State:Alabama United States North and Central America Cancer Glottic Cancer Glottic Carcinoma Health and Medicine Oncology 418 418 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Glottic Cancer have been published. [Extracted from the article]

Keywords: Nagoya; Japan; Asia; Adverse Drug Reactions; Cancer; Carcinomas; Drugs and Therapies; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Oncology; Pharmaceuticals; Radiation Therapy; Radiotherapy EN Nagoya Japan Asia Adverse Drug Reactions Cancer Carcinomas Drugs and Therapies Glottic Cancer Glottic Carcinoma Health and Medicine Oncology Pharmaceuticals Radiation Therapy Radiotherapy 314 314 1 07/03/23 20230707 NES 230707 2023 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Oncology - Glottic Cancer are presented in a new report. Keywords for this news article include: Nagoya, Japan, Asia, Adverse Drug Reactions, Cancer, Carcinomas, Drugs and Therapies, Glottic Cancer, Glottic Carcinoma, Health and Medicine, Oncology, Pharmaceuticals, Radiation Therapy, Radiotherapy, Nagoya University. Nagoya, Japan, Asia, Adverse Drug Reactions, Cancer, Carcinomas, Drugs and Therapies, Glottic Carcinoma, Glottic Cancer, Health and Medicine, Oncology, Pharmaceuticals, Radiation Therapy, Radiotherapy. [Extracted from the article]

For more information on this research see: Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system. Cancer, Drugs and Therapies, Glottic Carcinoma, Glottic Cancer, Health and Medicine, Oncology, Public Health, Radiotherapy Keywords: Cancer; Drugs and Therapies; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Oncology; Public Health; Radiotherapy EN Cancer Drugs and Therapies Glottic Cancer Glottic Carcinoma Health and Medicine Oncology Public Health Radiotherapy 741 741 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on glottic cancer is the subject of a new report. [Extracted from the article]

Keywords for this news article include: Evanston, Illinois, United States, North and Central America, Cancer, Glottic Cancer, Glottic Carcinoma, Health and Medicine, Oncology, NorthShore University Health System. Keywords: Evanston; State:Illinois; United States; North and Central America; Cancer; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Oncology EN Evanston State:Illinois United States North and Central America Cancer Glottic Cancer Glottic Carcinoma Health and Medicine Oncology 466 466 1 05/02/23 20230502 NES 230502 2023 MAY 2 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Oncology - Glottic Cancer. [Extracted from the article]

Keywords: Tokyo; Japan; Asia; Cancer; Carcinomas; Drugs and Therapies; Endocrine System Diseases and Conditions; Endocrinology; Glottic Cancer; Glottic Carcinoma; Health and Medicine; Hypothyroidism; Oncology; Radiotherapy; Risk and Prevention; Thyroid Diseases and Conditions EN Tokyo Japan Asia Cancer Carcinomas Drugs and Therapies Endocrine System Diseases and Conditions Endocrinology Glottic Cancer Glottic Carcinoma Health and Medicine Hypothyroidism Oncology Radiotherapy Risk and Prevention Thyroid Diseases and Conditions 1117 1117 1 03/24/23 20230217 NES 230217 2023 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on Oncology - Glottic Cancer are presented in a new report. According to news reporting originating from Tokyo, Japan, by NewsRx correspondents, research stated, "Hypothyroidism may occur after definitive radiotherapy in rare cases of early glottic carcinoma. [Extracted from the article]